Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novocuff has developed a vaginally-inserted, adjustable silicone medical device designed to stabilize the cervix, retain amniotic fluid, and extend pregnancy in women at risk for preterm birth due to PPROM or short cervix. The company has completed two feasibility studies—one for short cervix and one for PPROM—and is preparing a multi-center pivotal U.S. clinical trial in early 2025. Early results are promising but full pivotal data are pending.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novocuff.